Bedel Financial Consulting, Inc. Teva Pharmaceutical Industries LTD Transaction History

Bedel Financial Consulting, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$7.38 - $10.4 $6,826 - $9,620	-925 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$9.9 - $11.56 $6,435 - $7,514	650 Added 236.36%	925 $9,000
Q1 2018 May 03, 2018	BUY	$16.68 - $22.07 $4,587 - $6,069	275 New	275 $5,000

540

548M

19.8M

14M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.